Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Luca Cantarini, Claudia Fabiani et al.|Frontiers in Pharmacology|2019Cited by 616
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseasesGiulio Cavalli, Charles A. Dinarello, Serena Colafrancesco et al.|Autoimmunity Reviews|2021Cited by 330
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyMario Messina, Jurgen Sota, Antonio Vitale et al.|Clinical Rheumatology|2018Cited by 82
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-<i>α</i> Receptor—Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA NetworkCarla Gaggiano, Luca Cantarini, Antonio Vitale et al.|Mediators of Inflammation|2020Cited by 49
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Luca Cantarini, Donato Rigante et al.|Frontiers in Pharmacology|2019Cited by 45